Kurs & Likviditet
Kalender
2024-10-30 | Kvartalsrapport 2024-Q3 |
2024-07-17 | Kvartalsrapport 2024-Q2 |
2024-04-24 | Kvartalsrapport 2024-Q1 |
2024-04-12 | X-dag ordinarie utdelning BRG 3.75 NOK |
2024-04-11 | Årsstämma 2024 |
2024-01-31 | Bokslutskommuniké 2023 |
2023-10-24 | Kvartalsrapport 2023-Q3 |
2023-07-18 | Kvartalsrapport 2023-Q2 |
2023-05-03 | Kvartalsrapport 2023-Q1 |
2023-04-19 | X-dag ordinarie utdelning BRG 3.25 NOK |
2023-04-18 | Årsstämma 2023 |
2023-02-02 | Bokslutskommuniké 2022 |
2022-10-21 | Kvartalsrapport 2022-Q3 |
2022-07-15 | Kvartalsrapport 2022-Q2 |
2022-05-03 | Kvartalsrapport 2022-Q1 |
2022-04-08 | X-dag ordinarie utdelning BRG 2.75 NOK |
2022-04-08 | X-dag bonusutdelning BRG 2.25 |
2022-04-07 | Årsstämma 2022 |
2022-02-03 | Bokslutskommuniké 2021 |
2021-10-21 | Kvartalsrapport 2021-Q3 |
2021-07-15 | Kvartalsrapport 2021-Q2 |
2021-04-28 | Kvartalsrapport 2021-Q1 |
2021-04-15 | X-dag ordinarie utdelning BRG 2.50 NOK |
2021-04-14 | Årsstämma 2021 |
2021-02-03 | Bokslutskommuniké 2020 |
2020-10-21 | Kvartalsrapport 2020-Q3 |
2020-07-16 | Kvartalsrapport 2020-Q2 |
2020-06-16 | X-dag ordinarie utdelning BRG 2.30 NOK |
2020-06-15 | Årsstämma 2020 |
2020-04-29 | Kvartalsrapport 2020-Q1 |
2020-02-05 | Bokslutskommuniké 2019 |
2019-10-18 | Kvartalsrapport 2019-Q3 |
2019-07-16 | Kvartalsrapport 2019-Q2 |
2019-04-30 | Kvartalsrapport 2019-Q1 |
2019-04-12 | X-dag ordinarie utdelning BRG 2.25 NOK |
2019-04-11 | Årsstämma 2019 |
2019-01-31 | Bokslutskommuniké 2018 |
2018-10-23 | Kvartalsrapport 2018-Q3 |
2018-07-17 | Kvartalsrapport 2018-Q2 |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-04-13 | X-dag ordinarie utdelning BRG 2.00 NOK |
2018-04-12 | Årsstämma 2018 |
2018-02-02 | Bokslutskommuniké 2017 |
2017-10-24 | Kvartalsrapport 2017-Q3 |
2017-07-18 | Kvartalsrapport 2017-Q2 |
2017-05-03 | Kvartalsrapport 2017-Q1 |
2017-04-21 | X-dag bonusutdelning BRG 1.75 |
2017-04-21 | X-dag ordinarie utdelning BRG 1.75 NOK |
2017-04-20 | Årsstämma 2017 |
2017-02-10 | Bokslutskommuniké 2016 |
2016-10-21 | Kvartalsrapport 2016-Q3 |
2016-09-20 | Kapitalmarknadsdag 2016 |
2016-07-18 | Kvartalsrapport 2016-Q2 |
2016-04-27 | Kvartalsrapport 2016-Q1 |
2016-04-14 | X-dag ordinarie utdelning BRG 1.50 NOK |
2016-04-13 | Årsstämma 2016 |
2016-02-03 | Bokslutskommuniké 2015 |
2015-10-21 | Kvartalsrapport 2015-Q3 |
2015-07-15 | Kvartalsrapport 2015-Q2 |
2015-04-28 | Kvartalsrapport 2015-Q1 |
2015-04-16 | X-dag ordinarie utdelning BRG 1.25 NOK |
2015-04-15 | Årsstämma 2015 |
2015-02-04 | Bokslutskommuniké 2014 |
2014-10-22 | Kvartalsrapport 2014-Q3 |
2014-07-16 | Kvartalsrapport 2014-Q2 |
2014-04-29 | Kvartalsrapport 2014-Q1 |
2014-04-24 | X-dag ordinarie utdelning |
2014-04-23 | Årsstämma 2014 |
2014-03-11 | Kapitalmarknadsdag 2014 |
2014-02-05 | Bokslutskommuniké 2013 |
2013-10-29 | Kvartalsrapport 2013-Q3 |
2013-07-17 | Kvartalsrapport 2013-Q2 |
2013-04-30 | Kvartalsrapport 2013-Q1 |
2013-04-16 | X-dag ordinarie utdelning |
2013-04-15 | Årsstämma 2013 |
2013-02-06 | Bokslutskommuniké 2012 |
2013-01-10 | Extra Bolagsstämma 2013 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Material |
Industri | Plast, kemikalier & fetter |
Reference is made to the stock exchange release of 23 July 2021 regarding Borregaard’s investment in the marine biotech company Alginor ASA.
Borregaard has exercised its right to increase ownership in Alginor. The value of the equity transactions is approximately NOK 124 million of which NOK 120 million is a direct equity issue made exclusively to Borregaard. The remaining NOK 4 million are shares acquired from a company controlled by the Alginor founder. After these transactions and considering the employee share options program, Borregaard will hold 35% of the shares in Alginor on a fully diluted basis.
The direct equity issue will facilitate investments that shorten the time to market for commercial volumes of Alginor’s key product, alginate. This includes expanding parts of Alginor’s demonstration plant to semi-commercial scale and increasing the company’s harvesting capacity at an earlier stage.
To date, Borregaard’s committed investments in Alginor total approximately NOK 268 million.
For more information about Alginor, see https://alginor.no/.
Contact:
Director Investor Relations, Knut-Harald Bakke, +47 905 79 164
This information is subject to the disclosure requirements pursuant to Section 5 – 12 of the Norwegian Securities Trading Act.